Potential Drug-Drug Interaction (PDDI) Clinical Decision Support, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-ketoprofen-exclude | Version: 1.0.0 | ||||
| Standards status: Informative | Computable Name: Valueset_ketoprofen_exclude | ||||
Copyright/Legal: (copyright expectations unknown) |
|||||
ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)| Code | Display |
| 105999 | Ketoprofen 0.025 MG/MG Topical Gel |
| 1488714 | Ketoprofen 0.05 MG/MG Topical Powder |
| 377957 | Ketoprofen Topical Gel |
| 1488713 | Ketoprofen Topical Powder |
| 1160964 | Ketoprofen Topical Product |
| 1491501 | Ketoprofen / Lidocaine Topical Product |
Expansion from tx.fhir.org based on codesystem RxNorm v03022026 (CodeSystem)
This value set contains 6 concepts